Eloxx Pharmaceuticals Inc - Company Profile

Powered by

All the sales intelligence you need on Eloxx Pharmaceuticals Inc in one solution.

$ $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Eloxx Pharmaceuticals Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Eloxx Pharmaceuticals Inc.

Back to companies

Eloxx Pharmaceuticals Inc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

The following section provides information on Eloxx Pharmaceuticals Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Eloxx Pharmaceuticals Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Alan Walts

Chairman Executive Board Since: 2023 Age: 66

Mr. Alan Walts has been the Chairman of the company since 2023. Prior to this, he served as the Chairman of Zikani. Previously, he served as the Chairman of PIC Therapeutics and Artax Biopharma.

Read Hide full bio of Alan Walts

Sumit Aggarwal

President; Director; Chief Executive Officer Executive Board Since: 2021 Age: 54

Mr. Sumit Aggarwal has been the President, Chief Executive Officer, and Director of the company since 2021. Prior to this, he served as the President and Chief Executive Officer of Zikani. Mr. Aggarwal also served as the Acting President and Chief Financial Officer of Progenity Inc.

Read Hide full bio of Sumit Aggarwal

Daniel Geffken

Interim Chief Financial Officer Senior Management Since: 2021 Age: 69

Mr. Daniel Geffken has been the Interim Chief Financial Officer of the company since 2021. Prior to this, he served as the Chief Financial Officer of Apellis Pharmaceuticals. Mr. Geffken also served as the Chief Financial Officer of various companies including Cidara Therapeutics, GenePeeks, Homology Medicines, Stealth BioTherapeutics and Transkaryotic Therapies.

Read Hide full bio of Daniel Geffken

Steven D. Rubin

Director Non Executive Board Since: 2017 Age: 65
Gain a 360-degree view of Eloxx Pharmaceuticals Inc and make more informed decisions for your business Gain a 360-degree view of Eloxx Pharmaceuticals Inc and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer